Previously, many of the B16F10 antigens studied were either tumour-associated antigens (typically melanocyte differentiation antigens such as gp100 or Trp2)40–42 or OVA257-264, a foreign antigen engineered to be artificially expressed by B16F1032. The gene discussed is PMEL; the disease is neoplasm.